AbGenomics raised new fund for advancing its clinical trials and new linker-payload technology AbGenomics International announced today that it has raised $9.6 million in current financing round. (Photo: ...
Further consolidates the diversified product lines to drive sustainable growth Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral ...
AYX1 Injection Designated as a Fast Track Development Program for Prevention of Chronic Pain Adynxx, a clinical-stage pharmaceutical company developing a first-in-class platform of therapeutics to address pain at its molecular roots, announced ...
First of Six ORCA™ Trials to Reach Key Phase 2 Enrollment Milestone OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that enrollment has been completed in Borealis-1™, a company-sponsored, randomized, placebo-controlled Phase 2 ...
DART's Phase 1b/2a Study to Determine Safety and Tolerability of Lead Drug Candidate, Help Validate New Endpoint for Future DMD Studies DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for ...
No Late-Stage Emerging Therapies are Likely to Impact Overall Survival, Which is One of the Greatest Unmet Needs in the Indication, According to a New Report from Decision Resources Decision Resources, one of the world's leading research and ...
Results of four research trials investigating new targets for therapies in Alzheimer's disease, and incorporating novel approaches to participant identification and selection, were reported today at the Alzheimer's Association International ...
Approval supported by one of the largest Phase III trials in patients with EGFR mutation-positive advanced NSCLC Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GILOTRIF ™ ...
Echo Pharmaceuticals ("Echo") announces that Namisol ® has completed successfully a Phase II trial with 24 patients suffering from spasticity and pain due to multiple sclerosis (MS). The trial has been conducted by the Centre for Human Drug ...
Quantec presents results of clinical trial at New Zealand Dermatological Society Annual Meeting New Zealand-based dairy biotechnology company, Quantec Ltd, presented the results of its US clinical trial on acne to dermatologists at the New ...
Bharat Biotech, in collaboration with Biofabri, a Spanish biopharmaceutical firm, is conducting trials for the first live attenuated vaccine MTBVAC ( ) derived from a human strain of Mycobacterium tuberculosis. These trials aim to assess the safety and ...
A multisite clinical trial offers promising outcomes for patients with metastatic and recurrent uterine cancer, also known as endometrial cancer. Presented at the annual meeting of the Society of Gynecologic Oncologists, the study compiled data from ...
Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...
The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...
A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers